Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Klotho Neurosciences, Inc. (GRML) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-13.86M |
|
-- |
|
-- |
|
$9.51M |
|
$-9.51M |
|
$-4.34M |
|
$-13.86M |
|
$-11.81M |
|
$-13.86M |
|
$-13.86M |
|
$-13.86M |
|
$-11.81M |
|
$-9.51M |
|
$-7.47M |
|
93.73M |
|
93.73M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$10.93M |
|
-- |
|
$48.81M |
|
$59.74M |
|
$0.55M |
|
-- |
|
$7.71M |
|
$8.27M |
|
$51.47M |
|
$2.80M |
|
$51.47M |
|
121.24M |
|
| Cash Flow Statement Financials | |
$-4.97M |
|
$-0.37M |
|
$8.16M |
|
$7.18M |
|
$10.00M |
|
$2.83M |
|
$5.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.74 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.97M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-26.92% |
|
-495.29% |
|
-23.20% |
|
-26.92% |
|
$0.42 |
|
$-0.05 |
|
$-0.05 |
|